There are several studies suggesting dysregulated CRMP2 dynamics in Alzheimer’s disease and schizophrenia, yet it is unclear whether this is causal of disease presentation or simply a secondary effect of disease outcome [9–11]. This evidence concerns the gene DPYSL2 and early-onset autosomal dominant Alzheimer disease.